Fate Therapeutics Inc
FATE
Market Cap$443.89M
Close$
$8.54
109.3% upside
Current Fair Value
109.3% upsideUndervalued by 109.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $443.89 Million |
|---|---|
| Enterprise Value | $128.71 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.64 |
| Beta | 2.88 |
| Outstanding Shares | 113,816,708 |
| Avg 30 Day Volume | 2,811,898 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.76 |
|---|---|
| PEG | 12.7 |
| Price to Sales | - |
| Price to Book Ratio | 1.36 |
| Enterprise Value to Revenue | 2.03 |
| Enterprise Value to EBIT | -0.68 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Fate Therapeutics Inc
CEO: William Rastetter